Lunit Cancer Screening

Overview

Lunit Cancer Screening is a healthcare technology company specializing in artificial intelligence (AI) solutions for cancer diagnostics and treatment. Based in Seoul, South Korea, with a significant presence in Boston, Massachusetts, this organization leverages advanced AI software to support medical professionals in cancer screening and personalized treatment. Their mission centers on improving clinical outcomes through precision diagnosis and optimized treatment decisions.

The company’s offerings include the Lunit INSIGHT Suite for breast cancer detection and the Lunit SCOPE platform for biomarker analysis, both designed to enhance radiology efficiency and screening quality. In 2024, Lunit introduced a comprehensive cancer care ecosystem, integrating multiple AI technologies. Its solutions are deployed in over 4,800 medical institutions across more than 55 countries, demonstrating a robust global presence and collaboration with major medical device partners to expand their impact in cancer care.

Basic Information

Contact Details

• Website: lunit.io
• LinkedIn: linkedin.com/company/lunit

Key Focus Areas & Initiatives

• Deep learning for medical imaging
• AI-powered diagnostics and cancer screening
• AI software development for healthcare efficiency
• Cancer detection and biomarker analysis
• Global deployment of clinical AI solutions
• Integrated cancer care ecosystems
• Regulatory approved AI medical devices
• Improvement of patient outcomes and treatment optimization
• Collaborations with medical device companies
• Clinical validation and real-world studies

Technologies Used

• AI
• Amazon AWS
• Gmail
• Google AdWords Conversion
• Google Analytics
• Google Apps
• Google Tag Manager
• Hotjar
• Hubspot
• Linkedin Marketing Solutions
• Microsoft Office 365
• Mobile Friendly
• Nginx
• Outlook
• Remote
• Route 53
• Salesforce
• VueJS
• YouTube
• Zendesk

Affiliated Organizations & Regional Branches

• Volpara Health